171 related articles for article (PubMed ID: 19896210)
21. Variation in SNPs of the IL7Ra gene is associated with multiple sclerosis in the Iranian population.
Heidari M; Behmanesh M; Sahraian MA
Immunol Invest; 2011; 40(3):279-89. PubMed ID: 21190413
[TBL] [Abstract][Full Text] [Related]
22. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism.
Bilińska M; Frydecka I; Noga L; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Pokryszko-Dragan A
Acta Neurol Scand; 2004 Jul; 110(1):67-71. PubMed ID: 15180809
[TBL] [Abstract][Full Text] [Related]
23. IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis.
Sarial S; Shokrgozar MA; Amirzargar A; Shokri F; Radfar J; Zohrevand P; Arjang Z; Sahraian MA; Lotfi J
Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):37-40. PubMed ID: 18322311
[TBL] [Abstract][Full Text] [Related]
24. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
Perera D; Stankovich J; Butzkueven H; Taylor BV; Foote SJ; Kilpatrick TJ; Rubio JP
J Neuroimmunol; 2009 Jun; 211(1-2):105-9. PubMed ID: 19375175
[TBL] [Abstract][Full Text] [Related]
25. The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR.
Zivković M; Stanković A; Dincić E; Popović M; Popović S; Raicević R; Alavantić D
Clin Chim Acta; 2009 Aug; 406(1-2):27-30. PubMed ID: 19433080
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E genotype does not influence the progression of multiple sclerosis.
Savettieri G; Andreoli V; Bonavita S; Cittadella R; Caltagirone C; Fazio MC; Girlanda P; Le Pira F; Liguori M; Logroscino G; Lugaresi A; Nocentini U; Reggio A; Salemi G; Serra P; Tedeschi G; Toma L; Trojano M; Valentino P; Quattrone A
J Neurol; 2003 Sep; 250(9):1094-8. PubMed ID: 14504972
[TBL] [Abstract][Full Text] [Related]
27. Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus.
Sánchez E; Abelson AK; Sabio JM; González-Gay MA; Ortego-Centeno N; Jiménez-Alonso J; de Ramón E; Sánchez-Román J; López-Nevot MA; Gunnarsson I; Svenungsson E; Sturfelt G; Truedsson L; Jönsen A; González-Escribano MF; Witte T; ; Alarcón-Riquelme ME; Martín J
Arthritis Rheum; 2007 Sep; 56(9):3080-6. PubMed ID: 17763438
[TBL] [Abstract][Full Text] [Related]
28. Genetic association analysis of the interleukin 7 gene (IL7) in multiple sclerosis.
Lundmark F; Duvefelt K; Hillert J
J Neuroimmunol; 2007 Dec; 192(1-2):171-3. PubMed ID: 17913246
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
[TBL] [Abstract][Full Text] [Related]
30. Association between CD24-P226-C/T polymorphism and multiple sclerosis: a meta-analysis.
Jiang L; Bai X; Wang Y; Wei M
Immunol Invest; 2015; 44(4):321-30. PubMed ID: 25942344
[TBL] [Abstract][Full Text] [Related]
31. Interferon gamma allelic variants: sex-biased multiple sclerosis susceptibility and gene expression.
Kantarci OH; Hebrink DD; Schaefer-Klein J; Sun Y; Achenbach S; Atkinson EJ; Heggarty S; Cotleur AC; de Andrade M; Vandenbroeck K; Pelfrey CM; Weinshenker BG
Arch Neurol; 2008 Mar; 65(3):349-57. PubMed ID: 18332247
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the C/T(-1) single nucleotide polymorphism in the CD40 gene in multiple sclerosis.
Buck D; Kroner A; Rieckmann P; Mäurer M; Wiendl H
Tissue Antigens; 2006 Oct; 68(4):335-8. PubMed ID: 17026470
[TBL] [Abstract][Full Text] [Related]
33. No evidence of a significant role for CTLA-4 in multiple sclerosis.
Roxburgh RH; Sawcer S; Maranian M; Seaman S; Hensiek A; Yeo T; Deans J; Compston A
J Neuroimmunol; 2006 Feb; 171(1-2):193-7. PubMed ID: 16325273
[TBL] [Abstract][Full Text] [Related]
34. A PD-1 polymorphism is associated with disease progression in multiple sclerosis.
Kroner A; Mehling M; Hemmer B; Rieckmann P; Toyka KV; Mäurer M; Wiendl H
Ann Neurol; 2005 Jul; 58(1):50-7. PubMed ID: 15912506
[TBL] [Abstract][Full Text] [Related]
35. Profile of cytokine gene polymorphisms in Iranian multiple sclerosis patients.
Amirzargar A; Khosravi F; Dianat S; Hushmand F; Maryousef P; Foroushani AR; Lotfi J; Nikbin B
Mult Scler; 2007 Mar; 13(2):253-5. PubMed ID: 17439892
[TBL] [Abstract][Full Text] [Related]
36. IL23R: a susceptibility locus for celiac disease and multiple sclerosis?
Núñez C; Dema B; Cénit MC; Polanco I; Maluenda C; Arroyo R; de las Heras V; Bartolomé M; de la Concha EG; Urcelay E; Martínez A
Genes Immun; 2008 Jun; 9(4):289-93. PubMed ID: 18368064
[TBL] [Abstract][Full Text] [Related]
37. IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response.
Leyva L; Fernández O; Fedetz M; Blanco E; Fernández VE; Oliver B; León A; Pinto-Medel MJ; Mayorga C; Guerrero M; Luque G; Alcina A; Matesanz F
J Neuroimmunol; 2005 Jun; 163(1-2):165-71. PubMed ID: 15885318
[TBL] [Abstract][Full Text] [Related]
38. Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis.
Sombekke MH; Arteta D; van de Wiel MA; Crusius JB; Tejedor D; Killestein J; Martínez A; Peña AS; Polman CH; Uitdehaag BM
Mult Scler; 2010 Jun; 16(6):652-9. PubMed ID: 20378664
[TBL] [Abstract][Full Text] [Related]
39. Osteopontin gene and clinical severity of multiple sclerosis.
Hensiek AE; Roxburgh R; Meranian M; Seaman S; Yeo T; Compston DA; Sawcer SJ
J Neurol; 2003 Aug; 250(8):943-7. PubMed ID: 12928913
[TBL] [Abstract][Full Text] [Related]
40. Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland.
Greve B; Simonenko R; Illes Z; Peterfalvi A; Hamdi N; Mycko MP; Selmaj KW; Rozsa C; Rajczy K; Bauer P; Berger K; Weissert R
Mult Scler; 2008 Mar; 14(2):153-8. PubMed ID: 17942509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
